Stimulating platelet production with romiplostim is an effective strategy for managing patients with ITP. Thrombocytopenias can be caused by increased platelet destruction, decreased platelet ...

Rigel Pharmaceuticals, Inc.’s RIGL share price has dipped by 10.05%, which has investors questioning if this is right time to ...

The first patient has been enrolled in a Phase 1 trial by the NHLBI that's evaluating fostamatinib as a treatment for sickle ...

Feb. 5, 2025 — Could the key to easing anxiety be hidden in our gut? Scientists have discovered a crucial connection between gut microbes and anxiety-related behavior. Their research suggests ...

An orthopaedic surgeon discusses how this approach helps alleviate pain caused by joint injuries and chronic conditions.

Medically reviewed by Amy Kwan, PT Your latissimus dorsi (your "lats") is a broad, flat, triangle-shaped muscle that spans ...

Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...

Investment analysts at William Blair reduced their FY2025 earnings per share estimates for Amgen in a report released on Wednesday, February 5th. William Blair analyst M. Phipps now anticipates that ...

The European platelet rich plasma (PRP) market is poised for steady growth, with projections indicating a valuation exceeding ...

Research analysts at Cantor Fitzgerald reduced their FY2025 earnings estimates for Amgen in a research note issued to ...